InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 08/22/2019 2:50:29 PM

Thursday, August 22, 2019 2:50:29 PM

Post# of 507
News: $BTHE Boston Therapeutics Ph 2 Study Achieves Full Enrollment

LAWRENCE, Mass., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Boston Therapeutics (OTCQB:BTHE) is again pleased to announce full enrollment of the BTI320 Ph 2 double-blind, placebo-controlled, multicenter trial. With the recent inclusion of Miami Dade Medical Research Institute in June and IOWA Diabet...

Read the whole news Boston Therapeutics Ph 2 Study Achieves Full Enrollment